Read More

Size matters: Bimodal imaging receives nanoparticle enhancement

Tsukuba, Japan, Mar 10, 2021 - (ACN Newswire via SEAPRWire.com) - Scientists have found a way to control the size of special nanoparticles to optimize their use for both magnetic resonance and near-infrared imaging. Their approach could help surgeons use the same nanoparticles to visualize tumours just before and then during surgery using the two different imaging techniques. Their findings were published in the journal Science and Technology of Advanced Materials.The scientists injected the nanoparticle solution into the tail veins of live mice and were able to obtain high quality MRI (L) and near-infrared fluorescence (R) scans of tissues and blood vessels."Magnetic resonance imaging is routinely used in pre-operative diagnosis, while surgeons have started using near-infrared fluorescence imaging during surgical procedures," says nanobiotechnologist Kyohei Okubo of Tokyo University of Science. "Our nanoparticle probes could provide a bimodality that will be clinically appealing to medical device researchers and doctors."Ceramic nanoparticles made with the rare earth metals ytterbium (Yb) and erbium (Er) have demonstrated low toxicity and prolonged near-infrared luminescence, show...

Read More

Olympus to Acquire Quest Photonic Devices B.V. to Bolster Surgical Endoscopy Capabilities

Tokyo / Hamburg, Jan 28, 2021 - (ACN Newswire) - Olympus Corporation (Olympus - Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) today announced that it has entered into an agreement to acquire Quest Photonic Devices B.V. (Quest - CEO: Richard Meester) for up to EUR50 million including milestone payments to strengthen its surgical endoscopy capabilities.Headquartered in the Netherlands, Quest offers advanced fluorescence imaging systems (FIS) for the medical field, enabling more surgical endoscopy capabilities, compared to conventional imaging technologies.Fluorescence imaging refers to special light imaging technologies that utilize the properties of fluorescent dyes directed to specific anatomical structures. By using targeted dyes, in combination with specific light wavelengths, tissues or lesions that are nearly invisible under normal white light become visible. Olympus' existing laparoscopic imaging system, VISERA ELITE II, is already equipped with fluorescence imaging technology. VISERA ELITE II uses near-infrared light to identify blood vessels or lymph nodes under the surface tissues, aiming to assist surgeons in performing safer procedures wit...